Pharmacist

The mission of WHO in Myanmar is the attainment of the highest possible level of health by the people of Myanmar. In order to provide effective support, the WHO country office leverages the three levels of the Organization: to focus support where it can make a difference; to place the right people in the right places; to engage partners effectively; to enhance communications, and to improve operational intelligence. Priorities of WHO WHO’s general programme of work (GPW) sets medium-term priorities and strategies of the Organization.
The World Health Assembly in May 2018 is expected to approve the 13th general programme of work, covering the period 2019–2023. It encompasses a set of three interconnected strategic priorities,
strategic shifts and organizational shifts, as well as 10 outcomes to ensure healthy lives and promote wellbeing for all at all ages. The three strategic priorities are: Universal health coverage: 1 billion more people benefitting from universal health coverage Health emergencies: 1 billion more people better protected from health emergencies
Healthier populations: 1 billion more people enjoying better health and well-being

Additional Information

WHO is committed to workforce diversity.

WHO's workforce adheres to the WHO Values Charter and is committed to put the WHO Values into
practice. WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco.

The UNV assignment will be part of the WHO Country Office for Myanmar, Health Cluster and Humanitarian Structure. The mission of the Health Cluster is to collectively prepare for and responds to humanitarian and public health emergencies to improve health outcomes of affected populations in Myanmar, through timely, predictable, appropriate and effective coordinated health action. The Cluster operates in 6 core functions which are: support to service delivery, assessment and public health information, planning and health response strategy, M&E of health response, building capacity and advocacy.

Myanmar has activated its Health Cluster in Rakhine and Kachin in January 2013 and countrywide in August 2021.

The Public Health Information Service (PHIS) Standard https://www.who.int/publications/i/item/standards-for-public-health-information-services
is activated and expected to deliver with health cluster activation. Conceptually, the PHIS are grouped into the following three domains of information:
- Health Status and Threats for affected populations
- Health Resources and Services Availability, namely information on preventive and curative health services, infrastructure, personnel and supplies provided by health authorities or other actors, as well as the degree of access that affected populations actually have to those services.
- Health System Performance, namely information on the sheer output, coverage, utilization and quality (or effectiveness) of health services available to the crisis-affected population.

The PHIS Toolkit assembles guidance, templates and best-practice examples for each core, additional and context-specific public health information service, as outlined in the PHIS standards. The Toolkit also includes additional general tools and resources to support information management functions in activated Health Clusters – https://healthcluster.who.int/our-work/task-teams/information-management-task-team/public-health-information-services-toolkit.

Within the delegated authority and under the supervision of the Health Cluster Coordinator or his/ her designated mandated representative(s), the UN Volunteer will:
• Provide technical advice on pharmaceutical matters in all program cycle stages for WHO Myanmar, with a strong focus on project proposal development involving pharmaceutical procurement, forecasting and quantification of pharmaceutical supply, inventory man-agement and supply-chain related information systems.
• Provide technical advice on quality control and assurance systems for procurement, supply chain management, distribution and storage, including cold storage, of medical products and issues related to access of quality-assured medical products, market intel-ligence, pricing and the appropriate use of medical products at the various health care levels.
• Empower health partners with essential tools and guidance on quality assurance in local procurement of medical products, including the creation of checklists and standard oper-ating procedures (SOPs).
• Promote best practices for maintaining quality during storage and transport of medical products, including cold chain medicines, to prevent degradation and contamination, through the training of relevant staff.
• Develop mitigation plan to reduce, avoid, anticipate shortages of health products during the IMS Event Response including on prevention of AMR.
• Conduct a localized Market Quality Assessment and establish list of pre-qualified supplier (GMP and Certificate of Origin tracking matrix)
• Train health partners in quality assurance tools and checklists for locally procured phar-maceuticals to mitigate the risks of poor-quality medicines and AMR.
• Coordinate with other relevant Health Cluster partners as per identified needs, based on the above described Terms of Reference, to harness technical collaboration and knowledge development at the benefit of all Health Cluster members.